SCHEMBL7030187

SCHEMBL7030187

COC(C)(I)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19602885 0.76
SCHEMBL17994074 0.76
Iodine SCHEMBL1496823 0.67
SCHEMBL6223 0.64
SCHEMBL8679785 0.64 ALDH1A1 (1.00)
SCHEMBL503396 0.64
Phosphine SCHEMBL11650569 0.64
SCHEMBL763851 0.61
SCHEMBL7859981 0.61
SCHEMBL85676 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9069259-B2 Dynamic multi-purpose compositions for the removal of photoresists and method for its use DYNALOY, LLC (US) 2015-06-30 US claimed
US-4051172-A Molybdenum and tungsten compounds, their manufacture and their use as catalysts in the stereospecific polymerization of unsaturated organic compounds INSTITUT FRANCAIS DU PETROLE, DES CARBURANTS ET LUBRIFIANTS (FR) 1977-09-27 US claimed
EP-1389213-A1 3,7-DIAZABICYCLO 3.3.1] FORMULATIONS AS ANTIARHYTHMIC COMPOUNDS AstraZeneca AB (SE) 2004-02-18 EP disclosed
WO-2002083688-A1 3,7-DIAZABICYCLO [3.3.1] FORMULATIONS AS ANTIARHYTHMIC COMPOUNDS ASTRAZENECA AB (SE) 2002-10-24 WO disclosed
WO-1995033745-A9 NOVEL COMPOUNDS USEFUL IN MODULATING GENE EXPRESSION OF RETINOID RESPONSIVE GENES AND/OR HAVING ANTI-AP-1 ACTIVITY 1996-01-18 WO disclosed
EP-0151072-A2 Derivatives of methylenediphosphonic acid, process for their preparation and antirheumatic pharmaceutical compositions containing them SANOFI (FR) 1985-08-07 EP disclosed